Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Thoracic Malignancies × sintilimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 44 Stomach Neoplasms 36 Carcinoma, Non-Small-Cell Lung 30 Colorectal Neoplasms 19 Esophageal Squamous Cell Carcinoma 14 Nasopharyngeal Carcinoma 10 Lung Neoplasms 10 Rectal Neoplasms 7 Pancreatic Neoplasms 7 Esophageal Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Neoplasm Metastasis 5 Liver Neoplasms 5 Neoplasms 4 Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Lymphoma, Extranodal NK-T-Cell 3 Colorectal Cancer Metastatic 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Advanced Solid Tumors 3 Advanced Solid Tumor 3 Turcot syndrome 2 Thyroid Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Recurrence 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732430 2018-11-29

CARTAI

Taizhou Hospital

Phase 2 Unknown

Thoracic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡